Title | Pharmaceuticals Policy and Law |
Abbreviation | Pharm. Policy Law |
Publication Type | Journal |
Subject Area, Categories, Scope | Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4) |
h-index | 10 |
Overall Rank/Ranking | 23461 |
SCImago Journal Rank (SJR) | 0.119 |
Impact Score | 0.00 |
Publisher | IOS Press BV |
Country | Netherlands |
ISSN | 2210495X, 13892827 |
Pharmaceuticals Policy and Law is a journal covering the technologies/fields/categories related to Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4). It is published by IOS Press BV. The overall rank of Pharmaceuticals Policy and Law is 23461. According to SCImago Journal Rank (SJR), this journal is ranked 0.119. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 10. The best quartile for this journal is Q4.
The ISSN of Pharmaceuticals Policy and Law journal is 2210495X, 13892827. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Pharmaceuticals Policy and Law is cited by a total of 4 articles during the last 3 years (Preceding 2021).
The impact score (IS) 2021 of Pharmaceuticals Policy and Law is 0.00, which is computed in 2022 as per its definition. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2021 of Pharmaceuticals Policy and Law is 0.00. If the same downward trend persists, impact score may fall in 2022 as well.
Year | Impact Score (IS) |
---|---|
2022/2023 | Coming Soon |
2021 | 0.00 |
2020 | 0.05 |
2019 | 0.16 |
2018 | 0.30 |
2017 | 0.04 |
2016 | 0.09 |
2015 | 0.03 |
2014 | 0.24 |
Pharmaceuticals Policy and Law has an h-index of 10. It means 10 articles of this journal have more than 10 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Pharmaceuticals Policy and Law is 2210495X, 13892827. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Pharmaceuticals Policy and Law is 23461. According to SCImago Journal Rank (SJR), this journal is ranked 0.119. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Pharmaceuticals Policy and Law is published by IOS Press BV. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 1999, 2001-2002, 2005, 2007-2018. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Pharmaceuticals Policy and Law is Pharm. Policy Law. This abbreviation ('Pharm. Policy Law') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
BMC Oral Health | journal | 5841 | BioMed Central Ltd. | 56 | 3.73 |
IUCN/SSC Otter Specialist Group Bulletin | journal | 17114 | 7 | 0.32 | |
Journal of Youth Development | journal | 14795 | University Library System, University of Pittsburgh | 6 | 0.99 |
Global Health Promotion | journal | 11210 | SAGE Publications Ltd | 33 | 1.39 |
Kinematics and Physics of Celestial Bodies | journal | 19697 | Pleiades Publishing | 12 | 0.41 |
Revista de la Union Matematica Argentina | journal | 14552 | Union Matematica Argentina | 13 | 0.66 |
Drug and Chemical Toxicology | journal | 12030 | Informa Healthcare | 46 | 2.32 |
Stochastic Models | journal | 14385 | Taylor and Francis Ltd. | 37 | 0.71 |
International Journal of Sustainable Energy | journal | 9136 | Taylor and Francis Ltd. | 33 | 3.12 |
Journal of Building Engineering | journal | 3214 | Elsevier BV | 54 | 7.09 |
Year | Impact Score (IS) |
---|---|
2022/2023 | Coming Soon |
2021 | 0.00 |
2020 | 0.05 |
2019 | 0.16 |
2018 | 0.30 |
2017 | 0.04 |
2016 | 0.09 |
2015 | 0.03 |
2014 | 0.24 |